2,283
Views
0
CrossRef citations to date
0
Altmetric
Review

Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers

, & ORCID Icon
Pages 1033-1044 | Received 11 Mar 2022, Accepted 09 Aug 2022, Published online: 18 Aug 2022

References

  • Rau JL. The inhalation of drugs: advantages and problems. Resp Care. 2005;50(3):367–382. •• One of the first critical (comparative) evaluations regarding the efficacy of pulmonary drug delivery devices.
  • Anderson PJ. History of aerosol therapy: liquid nebulization to MDIs to DPIs. Resp Care. 2005;50(9):1139–1150.
  • Sanders M. Inhalation therapy: an historical review. Prim Care Resp J. 2007;16(2):71–81.
  • Sehata M. History of inhalation iherapy. Internet J Health. 2008;9(1):1–9.
  • Stein WS, Thiel CG. The history of therapeutic aerosols: a chronical review. J Aerosol Med Pulm Drug Deliv. 2017;30(1):20–41.
  • Rudén J. Powder mechanics and dispersion properties of adhesive mixtures for dry powder inhalers, conceptualized as a blend state model [Thesis]. Sweden: University of Uppsala, Dept Pharm Bioscience, 2021, pp 16–21.
  • Rospond B, Krakowska A, Muszyńska B, et al. The history, current state and perspectives of aerosol therapy. Acta Pharm. 2022;72(2):225–243.
  • Prime D, Atkins PJ, Slater A, et al. Review of dry powder inhalers. Adv Drug Deliv Rev. 1997;26(1):51–58.
  • Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Resp Med. 2002;96(5):293–304.
  • Atkins PJ. Dry powder inhalers: an overview. Resp Care. 2005;50(10):1304–1312.
  • Young PM, Traini D, Coates M, et al. Dry powder inhalers: challenges and goals for next generation therapies. Pharm Tech Europe. 2007;19(4):1–17.
  • Reddy SC. Past and present trends of dry powder inhaler devices: a review. J Drug Deliv Therapeutics. 2014;4(1):97–107.
  • Berkenfeld K, Lamprecht A, McConville, et al. Devices for dry powder drug delivery to the lung. AAPS PharmSciTech. 2015;16(3):479–490.
  • de Boer AH, Hagedoorn P, Hoppentocht M, et al. Dry powder inhalation: past, present and future. Exp Opion Drug Deliv. 2017;14(4):499–512.
  • Metha PP. Dry powder inhalers: upcoming platform technologies for formulation development. Ther Deliv. 2019;10(9):551–554.
  • Xiroudaki S, Schoubben A, Giovagnoli S, et al. Dry powder inhalers in the digitalization era: current status and future perspectives. Pharmaceutics. 2021;13(9):1455.
  • Dolgin E. The tangled history of mRNA vaccines. Nature. 2021;597(7876):318–324.
  • Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics – developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–780.
  • Lagendijk VC. Electrifying Europe: the power of Europe in the construction of electricity networks. Thesis Techn. The Netherlands: University Eindhoven, 2008, pp. 15–104.
  • Chalmin P. The history of plastics: from the capitol to the Tarpeian rock. Open Edition J. 2019;19:6–11.
  • Maglione M, Miotto K, Iguchi M, et al. Psychiatric effects of Ephedra use: an analysis of food and drug administration reports of adverse events. Am J Psychiatry. 2005;162(1):189–191.
  • Miller SC. Psychiatric effects of Ephedra: addiction. Am J Psychiatry. 2005;162(11):2198.
  • Sheik Ali B, Sathiswara B. Atropine induced psychosis: a report of two cases. Int J Health Sci Res. 2017;7(12):325–327.
  • Picciotto MR, Kenny PJ. Mechanisms of nicotine addiction. Cold Spring Harb Perspect Med. 2021;11(5):a039610.
  • Charlton A. Medicinal uses of tobacco in history. J R Soc Med. 2004;97(6):292–296.
  • Jackson M. “Devine Stramonium”: the rise and fall of smoking for asthma. Med Hist. 2010;54(2):171–194.
  • Wasik AA, Tuuminen T. Salt therapy as a complementary method for the treatment of respiratory tract diseases, with a focus on mold-related illness. Altern Ther Health Med. 2021;27(S1):223–239.
  • Antonelli M, Donelli D, Barbieri G, et al. Forest volatile organic compounds and their effects on human health: a state-of-the-art review. Int J Environ Res Public Health. 2020;17(18): 6506.
  • Miller WF. Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med. 1973;131(1):148–155.
  • Dessanges J-F. A history of nebulization. J Aerosol Med. 2001;14(1):65–71.
  • Barberis I, Bragazzi NL, Galluzzo L, et al. The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus. J Prev Med Hyg. 2017;58(1):E9–12.
  • Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of Ma-Huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000;56(2):424–430.
  • Jiao, Jao J, Wu J, et al. Ma Huang Tang ameliorates bronchial asthma symptoms through the TLR9 pathway. Pharm Biol. 2018;56(1):580–593.
  • Veith I. The yellow emperor’s classic of internal medicine. Berkeley and Los Angeles: University of California Press; 1966.
  • ItsHaky B. Huang Di Nei Jing Ling Shu; The ancient classic on needle therapy; the complete Chinese text with an annotated English translation. J Altem Complement Integr Med. 2017;3:20.
  • Kan LB. Introduction to Chinese medical literature. Bull Med Libr Assoc. 1965;53(1):60–67.
  • Watson B. Ssu-ma Ch’ien Grand historian of China. New York: Columbia University Press; 1963.
  • Chi-min W. China’s contribution to medicine in the past. Annals of Medical History. 1926;VIII:192–201.
  • Metwaly AM. Traditional ancient Egyptian medicine: a review. Saudi J Biological Sci. 2021;28(10):5823–5832.
  • Ebbel B. The Papyrus Ebers, the greatest Egyptian medical document. Copenhagen: Levin & Munksgaard; 1937.
  • Popko L, Schneider UJ, Scholl R, et al. Papyrus Ebers: Die grösste Schriftrolle zur altägyptischen Heilkunst. Darmstadt: WBG; 2021. • Very interesting renewed translation of the Papyrus Ebers with annotations (in German).
  • Cohen SG. Asthma in antiquity: the Ebers Papyrus. Allergy Proc. 1992;13(3):147–154.
  • Karamanou M, Androutsos G. Aretaeus of Cappadocia and the first clinical description of asthma, letter to the editor. Am J Respir Crit Care Med. 2011;184(12):1420–1421.
  • Alizadeh A, Moshiri M, Alizadeh J, et al. Black henbane and its toxicity – a descriptive review. Avicenna J Phytomed. 2014;4(5):297–311.
  • Raju VK. Susruta of ancient India. Indian J Ophthalmol. 2003;51(2):119–122.
  • Loukas M, Lanteri A, Ferrauiola J, et al. Anatomy in ancient India: a focus on the Susruta Samhita. J Anat. 2010;217(6):646–650.
  • Panda AK, Doddanagali SR. Clinical efficacy of herbal Padmapatradi yoga in bronchial asthma (Tamaka Swasa). J Ayurveda Integrative Med. 2011;2(2):85–90.
  • Patwardhan K. The history of the discovery of blood circulation: unrecognized contributions of ayurveda masters. Adv Physiol Educ. 2012;36(2):77–82.
  • Bhavana KR, Shreevathsa S. Medical geography in Charaka Samhita. AYU Int Q J Res Ayurveda. 2014;35(4):371–377.
  • Mukherjee PK, Harwansh RK, Bahadur S, et al. Development of ayurveda - tradition to trend. J Ethnopharmacol. 2017;197:10–24.
  • Meulenbeld GJ. A history of Indian medical literature, part 1A, Vol 1. Brill/Schöningh Verlag: Paderborn; 2002.
  • Pappas G, Kiriaze IJ, Falagas ME, et al. Insights into infectious disease in the era of Hippocrates. Int J Infect Disease. 2008;12(4):347–350.
  • Redman Coxe J. The writings of Hippocrates and Galen, epitomised from the original latin translations. Philadelphia: Lindsay and Blakiston; 1846. •• Highly interesting commentary on translated medical treatises written by Hippocrates (of Kos) and Claudius Galenus to those admiring ancient Greek medical knowledge.
  • Brownstein, Brownstein KJ, Tushingham S, et al. An ancient residue metabolomics-based method to distinguish use of closely related plant species in ancient pipes. Front Mol Biosci. 2020;7:133.
  • Saxena G, McCutcheon AR, Farmer S, et al. Antimicrobial constituents of Rhus glabra. J Ethnopharmacol. 1994;43(2):95–99.
  • Sanchez-Ramos JR. The rise and fall of tobacco as a botanical medicine. J Herbal Med. 2020;22:100374.
  • Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tob Control. 2012;21(2):87–91.
  • Ren M, Tang Z, Wu X, et al. The origins of cannabis smoking: chemical residue evidence from the first millennium BCE in the Pamirs. Sci Adv. 2019;5(6):eaaw1391.
  • Amr SS, Tbakhi A. Abu Bakr Muhammad Ibn Zakariya Al Razi (Rhazes): philosopher, physician and alchemist. Ann Saudi Med. 2007;27(4):305–307.
  • McCall T. Medical knowledge in the early medieval period. British Library. 2021. [cited Dec 2021]. Available from: https://www.bl.uk/medieval-english-french-manuscripts/articles/medical-knowledge-in-the-early-medieval-period?
  • Wishah G. Ibn Sina’s role in scientific discoveries. Asian J Humanities Social Studies. 2018;6(6):193–200.
  • Gea J. Maimonides, the respiratory system and personalized medicine. Open Respir Arch. 2019;1(1–2):3–4.
  • Cohen SG. Food allergens: landmarks along a historic trail. J Allergy Clin Immunol. 2008;121(6):1521–1524.
  • Zaikon SJ. Maimonides 1135-1204. Q Bull Northwest Univ Med Sch. 1959;33(1):71–76.
  • Beyar R, Skorecki K, Blazer S. The Maimonides heritage: discovery and propagation of medical knowledge. Rambam Maimonides Med J. 2018;9(3):e0017.
  • Miller MJ, Albarracin-Jordan J, Moore C, et al. Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. PNAS. 2019;116(23):11207–11212.
  • Newton AV. Inhaling apparatus. English patent 1161. 1964
  • Hassall AH. The inhalation treatment of diseases of the organs of respiration: including consumption. London: Longmans, Green, and Co; 1885.
  • McGinnis JD, Carlill V. Carbolic smoke ball company: influenza, quackery, and the unilateral contract. Can Bull Med Hist. 1988;5:121–141, CBMH/BCHM
  • Farber JE, Ross J. The use of aerosol Penicillin and Streptomycin in bronchopulmonary infections. Calif Med. 1950;73(3):214–217.
  • Svizzero S. Persistent controversies about the Neolithic revolution. J Hs Arch & Anthropol Sci. 2017;1(2):53–56. •• Critical evaluation of the debates about the presumed superiority of farming over foraging and the origin and spread of the Neolithic revolutions.
  • Smith ME. Gordon childe and the Urban revolution: a historical perspective on a revolution in urban studies. Trp. 2009;80(1):3–29.
  • McFadden ER. A century of asthma. Am J Respir Crit Care Med. 2004;170(3):215–221.
  • Blevins SM, Bronze MS. Robert Koch and the ‘golden age’ of bacteriology. Int J Infect Diseases. 2010;14(9):e744–e51.
  • Münch R. Robert Koch. Microbes Infect. 2003;5(1):69–74.
  • Williams DW. The germs-theory. Br Med J. 1871 April;8(536):368.
  • Gaynes R. The discovery of Penicillin – new insights after more than 75 years of clinical use. Emerging Infect Dis. 2017;23(5):849–853.
  • Zaitlin M. The discovery of the causal agent of the tobacco Mosaic disease. In: Kung SD, Yang SF, editors. Discoveries in plant biology. Hong Kong: World Publishing Co. Ltd; 1998. p. 105–110.
  • Pirofski L-A, Casadevall A. What is infectiveness and how is it involved in infection and immunity? BMC Immunol. 2015;16(1):13.
  • Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433.
  • Gygli SM, Borrell S, Trauner A, et al. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev. 2017;41(3): 354–373.
  • Traini D, Young PM. Drug delivery for tuberculosis: is inhaled therapy the key to success? Ther Deliv. 2017;8(10):819–821.